Common Misconceptions About GLP-1 Drugs Like Ozempic and Wegovy
Approximately 40 million Americans are currently taking GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro, driving a 500% surge in national spending from $13.7 billion in 2018 to $71.7 billion in 2023, according to a poll by the Kaiser Family Foundation and healthcare data. Despite the massive adoption of these treatments, widespread misconceptions persist regarding … Read more